FDA Publishes Guidance on Rare Pediatric Disease Priority ReviewAllbiopro2019-08-09T10:45:35+09:008월 9th, 2019|
FDA Gives Guidance on Developing Treatments for Fabry DiseaseAllbiopro2019-08-09T10:45:00+09:008월 9th, 2019|
Sartorius Stedim Biotech Launches New Mammalian Cell Bank ServicesAllbiopro2019-08-09T10:44:32+09:008월 9th, 2019|
CPhI MEA expert: ‘growing domestic manufacturing is creating new opportunities for international Pharma in the Middle East’Allbiopro2019-08-06T14:38:53+09:008월 6th, 2019|
Updated real-world data show Gilotrif® followed by osimertinib provided a median overall survival of up to almost four years in patients with EGFR Del19 and T790M mutation-positive NSCLCAllbiopro2019-08-06T14:37:57+09:008월 6th, 2019|
Insulet Reports Second Quarter 2019 Revenue of $177 Million, an Increase of 43% Year-Over-YearAllbiopro2019-08-06T14:36:59+09:008월 6th, 2019|
Augmenting Sales and Profitability for a Pharmaceutical Company | Quantzig’s Latest Customer Segmentation Analytics EngagementAllbiopro2019-08-06T14:36:03+09:008월 6th, 2019|
First Patient Enrolled in RGN-137 Trial for Epidermolysis Bullosa Experiences Complete Wound HealingAllbiopro2019-08-06T14:35:05+09:008월 6th, 2019|
Precigen Announces First Patient Dosed in Phase 1 Study of PRGN-3005 UltraCAR-T™ in Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal CancerAllbiopro2019-08-06T14:34:09+09:008월 6th, 2019|
Lenus Therapeutics Announces the Result of Complete Wound Healing on the Index Lesion of the First Subject in an Ongoing Single-Masked Phase 2 Trial with RGN-137 Dermal Gel for Epidermolysis BullosaAllbiopro2019-08-06T14:33:09+09:008월 6th, 2019|
Alnylam Announces U.S. Food and Drug Administration (FDA) Granted Priority Review of the Givosiran New Drug Application (NDA) for the Treatment of Acute Hepatic PorphyriaAllbiopro2019-08-06T14:32:10+09:008월 6th, 2019|
Eiger BioPharmaceuticals to Participate in Investor Conferences in AugustAllbiopro2019-08-06T14:31:13+09:008월 6th, 2019|
Acceleron Reports Second Quarter 2019 Operating and Financial ResultsAllbiopro2019-08-06T14:30:18+09:008월 6th, 2019|
Guardant Health’s Blood Test Could Replace Biopsy for Certain Types of CancerAllbiopro2019-08-06T14:29:20+09:008월 6th, 2019|
Pfizer’s Rivipansel Fails to Meet Primary and Secondary Efficacy Endpoints in Sickle Cell TrialAllbiopro2019-08-06T14:28:26+09:008월 6th, 2019|
Canada Urges Industry to Prepare for U.S. Drug Import ChangesAllbiopro2019-08-06T14:27:32+09:008월 6th, 2019|
